Prediction of nitric oxide concentrations in melanomas

Nitric Oxide - Biology and Chemistry

Volumn 23, Issue 4, 2010, Pages 319-326

  Chin, Melanie P ^a   Deen, William M ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Melanoma; Nitric oxide consumption by cells; Nitric oxide diffusion

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ARTICLE; AUTOOXIDATION; CELL KINETICS; CONCENTRATION (PARAMETERS); ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MACROPHAGE; MATHEMATICAL MODEL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; STROMA CELL;

COMPUTER SIMULATION; DIFFUSION; HUMANS; KINETICS; MACROPHAGES; MELANOMA; NITRIC OXIDE; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77958152494     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2010.09.003     Document Type: Article

References (50)

1. Grimm E.A., Ellerhorst J., Tang C., Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis. Nitric Oxide 2008, 19:133-137.
2. Balch C.M., Soong S., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N., Urist M., McMasters K.M., Ross M.I., Kirkwood J.M., Atkins M.B., Thompson J.A., Coit D.G., Byrd D., Desmond R., Zhang Y., Liu P., Lyman G.H., Morabito A. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 2001, 19:3622-3634.
3. Ekmekcioglu S., Ellerhorst J.A., Prieto V.G., Johnson M.M., Broemeling L.D., Grimm E.A. Tumor iNOS predicts poor survival for stage III melanoma patients. Int. J. Cancer 2000, 119:861-866.
4. Tang C., Grimm E.A. Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines. J. Biol. Chem. 2004, 279:288-298.
5. Morton D.L., Essner R., Kirkwood J.M., Wollman R.C. Malignant melanoma. Cancer Medicine 2006, 1640-1662. American Association for Cancer Research, New York. D.W. Kuff, R.C. Bast, W.N. Hait, W.K. Hong, R.E. Pollock, R.R. Weichselbam, J.F. Holland, E. Frei (Eds.).
6. Torisu H., Ono M., Kiryu H., Furue M., Ohmoto Y., Nakayama J., Nishioka S.S., Kuwano M. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF-α and Il-1α. Int. J. Cancer 2000, 85:182-188.
7. Subczynski W.K., Lomnicka M., Hyde J.S. Permeability of nitric oxide through lipid bilayer membranes. Free Radic. Res. 1996, 24:343-349.
8. Zacharia I., Deen W.M. Diffusivity and solubility of nitric oxide in water and saline. Ann. Biomed. Eng. 2005, 33:214-222.
9. Lewis R.S., Deen W.M. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem. Res. Toxicol. 1994, 7:568-574.
10. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 1992, 298:446-451.
11. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993, 18:195-199.
12. Gardner P.R., Gardner A.M., Martin L.A. Nitric oxide dioxygenase activity and function of flavohemoglobins. J. Biol. Chem. 2000, 275:31581-31587.
13. Eich R.F., Li T.S., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Mathews A.J., Johnson K.A., Smith R.D., Phillips G.N., Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996, 35:6976-6983.
14. 2. Proc. Natl. Acad. Sci. USA 2001, 98:355-360.
15. Nalwaya N., Deen W.M. Nitric oxide, oxygen, and superoxide formation and consumption in macrophage cultures. Chem. Res. Toxicol. 2005, 18:486-493.
16. Chin M.P., Schauer D.B., Deen W.M. Nitric oxide, oxygen, and superoxide synthesis and consumption in macrophages and colonic epithelial cells. Chem. Res. Toxicol. 2010, 23:778-787.
17. Babior B.M. The respiratory burst of phagocytes. J. Clin. Invest. 1984, 73:599-601.
18. Berton G., Dusi S., Bellavite P. The respiratory burst of phagocytes. The Respiratory Burst and its Physiological Significance 1988, 33-52. Plenum Press, New York. A.J. Sbarra, R.R. Strauss (Eds.).
19. Chen B., Deen W.M. Effect of liquid depth on the synthesis and oxidation of nitric oxide in macrophage cultures. Chem. Res. Toxicol. 2002, 15:490-496.
20. 2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 2004, 14:161-175.
21. Keynes R.G., Griffiths C., Garthwaite J. Superoxide-dependent consumption of nitric oxide in biological media may confound in vitro experiments. Biochem. J. 2003, 369:399-406.
22. Sheridan J.W., Bishop C.J., Simmons R.J. Biophysical and morphological correlates of kinetic change and death in a starved human melanoma cell line. J. Cell Sci. 1981, 49:119-137.
23. Lange's Handbook of Chemistry. rev. 10th ed. 1967, McGraw-Hill, New York, pp. 1101. N.A. Lange (Ed.).
24. Ellsworth M.L., Pittman R.N. Heterogeneity of oxygen diffusing through hamster striated muscles. Am. J. Physiol. Heart Circ. Physiol. 1983, 246:H161-H167.
25. Leskovar A., Moriarty L.J., Turek J., Schoenlein I., Borgens R.B. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 2000, 203:1783-1795.
26. Wang C., Trudel L., Wogan G.N., Deen W.M. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Chem. Res. Toxicol. 2003, 16:1004-1013.
27. Maciejewski J.P., Selleri C., Sato T., Cho H.J., Keefer L.K., Nathan C.F., Young N.S. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J. Clin. Invest. 1995, 96:1085-1092.
28. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2:907-916.
29. Geller D.A., Nussler A.K., Di Silvo M., Lowenstein C.J., Shapiro R.A., Wang S.C., Simmons R.L., Billiar T.R. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 1993, 90:522-526.
30. Chan E.D., Winston B.W., Uh S., Murray W.W., Rose D.M., Riches W.H. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthetase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 1999, 162:415-422.
31. Busam K.J., Antonescu C.R., Marghoob A.A. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. Am. J. Clin. Pathol. 2001, 115:856-860.
32. Bröcker E.B., Zwaldo G., Holzmann B., Macher E., Sorg C. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int. J. Cancer 1988, 41:562-567.
33. Angulo I., Rullas J., Campillo J.A., Obregon E., Heath A., Howard M., Munoz-Fernandez M.A., Subiza J.L. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1alpha. Eur. J. Immunol. 2000, 30:1263-1271.
34. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., Nathan C., Fidler I.J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 1995, 181:1333-1343.
35. Andrews P.J., Harant H., Lindley I.J.D. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 1995, 214:946-949.
36. Gardner P.R., Martin L.A., Hall D., Gardner A.M. Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Radic. Biol. Med. 2001, 31:191-204.
37. Dadras S., Paul T., Bertoncini J., Brown L.F., Muzikansky A., Jackson D.G., Ellwanger U., Garbe C., Mihm M.C.C., Detmar M. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol. 2003, 162:1951-1960.
38. Kiss J., Timar J., Somlai B., Gilde K., Fejos Z., Gaudi I., Ladanyi A. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathol. Oncol. Res. 2007, 13:21-31.
39. m for oxygen of nitric oxide synthase isoforms. J. Pharmacol. Exp. Ther. 1996, 276:30-33.
40. Salvucci O., Carsana M., Bersani I., Tragni G., Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res. 2001, 61:318-326.
41. Ahmed B., Van Den Oord J.J. Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin. Br. J. Dermatol. 1999, 141:12-19.
42. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Ann. Rev. Immunol. 1997, 14:323-350.
43. 2 in the microcirculation: a mathematical analysis. Microvasc. Res. 2004, 68:38-50.
44. Chin M.P., Schauer D.B., Deen W.M. Prediction of nitric oxide concentrations in the colonic crypt during inflammation. Nitric Oxide 2008, 19:266-275.
45. Giorgadze T.A., Zhang P.J., Pasha T., Coogan P.S., Acs G., Elder D.E., Xu X. Lymphatic vessel density is significantly increased in melanoma. J. Cutan. Pathol. 2004, 31:672-677.
46. Straume O., Jackson D.G., Akslen L.A. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin. Cancer Res. 2003, 9:250-256.
47. Massi D., De Nisi M.C., Franchi A., Mourmouras V., Baroni G., Panelos J., Santucci M., Miracco C. Inducible nitric oxide synthase expression in melanoma; implications in lymphangiogenesis. Mod. Pathol. 2009, 22:21-30.
48. Franchi A., Massi D., Santucci M., Masini E., Degl'Innocenti D.R., Magnelli L., Fanti E., Naldini A., Ardinghi C., Carraro F., Gallo O. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J. Pathol. 2005, 208:439-445.
49. Nakamura Y., Yasuoka H., Tsujimoto M., Yoshidome K., Nakahara M., Nakao K., Nakamura M., Kakudo K. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin. Cancer Res. 2006, 12:1201-1207.
50. Lim C.H., Dedon P.C., Deen W.M. Kinetic analysis of intracellular concentrations of reactive nitrogen species. Chem. Res. Toxicol. 2008, 21:2134-2147.